Novel early‐onset Alzheimer‐associated genes influence risk through dysregulation of glutamate, immune activation, and intracell signaling pathways

新型早发性阿尔茨海默病相关基因通过谷氨酸失调、免疫激活和细胞内信号通路影响患病风险

阅读:1

Abstract

BACKGROUND: Alzheimer Disease (AD) is a highly polygenic dementia that presents with relatively earlier onset (≤65yo; EOAD) in about 5% of cases. Around 90% of these EOAD cases remain unexplained by pathogenic mutations. METHOD: We used data from EOAD cases ≤ 70 and controls > 70 to ensure they would not develop AD. genome‐wide association study (GWAS) and trans‐ancestry meta‐analysis were performed for non‐Hispanic European (EUR, N(Case)=6,282, N(Control)=13,386), African (AFR N(Case)=782, N(Control)=3,663) and East Asian (ASN: N(Case)=375, N(Control)=838 CO) ancestries. We performed QTL mapping and in‐silico annotation to identify the functional gene for each genome‐wide loci, and PRS and LDSC to compare the genetic architecture of EOAD vs LOAD RESULT: We identified a total of 15 genome‐wide significant loci, 7 already reported to be associated with LOAD and 8 novel loci. Of the novel loci: six were found in the ancestry‐specific analyses and two in the trans‐ancestry analysis. By integrating gene‐based analysis, eQTL, pQTL and functional annotations, we nominate four novel functional genes (CDH12, FOLH1, ALG10B and LRRC25) for four loci that are involved in microglia activation, glutamate production, and signaling pathways. LOAD‐derived PRS showed a strong association with EOAD (R(2)=0.170, p <10(‐300), and R(2)=0.048, p = 1.20×10(‐143): for PRS with and without APOE). LDSC found strong overall genetic covariance between EOAD and LOAD (rg=0.791, p = 6.80×10(‐12)) CONCLUSION: These results indicate that EOAD, although sharing many genes with LOAD, harbors unique genes and pathways that could be used to create better prediction models or target identification for this type of AD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。